{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:30:19Z","timestamp":1787671819782,"version":"build-2736575974"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005760","name":"University of Gothenburg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005760","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cardiometabolic diseases often cluster as multimorbidity, yet current risk prediction models typically focus on a single disease and rarely incorporate social determinants. This study aims to develop a Bayesian risk prediction model for cardiometabolic multimorbidity in middle-aged Swedish adults. This prospective cohort included 11,964 adults without prior cardiometabolic disease from the Swedish CArdioPulmonary bioImage Study (SCAPIS; enrolment 2013\u20132016). Cardiometabolic disease was defined as incident type 2 diabetes (T2D), ischaemic heart disease\/heart failure, or stroke. Regularised Bayesian logistic regression models were developed to predict any cardiometabolic disease (\u2265\u20091 condition) and cardiometabolic multimorbidity (\u2265\u20092 conditions) within 2\u20135 years. Twenty-two social and cardiometabolic risk predictors were considered. During follow-up, 6.0% of participants developed cardiometabolic disease(s) (5.7% with a single cardiometabolic disease and 0.3% with multimorbidity). The prediction model showed fair discrimination for any cardiometabolic disease (AUC 0.76, 95% CI 0.74\u20130.78) and good discrimination for multimorbidity (AUC 0.89, 95% CI 0.86\u20130.93). The highest predicted risks were observed among older foreign-born males with hypertension, low HDL-C, high waist circumference, and current\/ex-smoker, with predicted risks of 34.7% (95% CrI 30.3%\u201339.5%) for any cardiometabolic disease and 4.4% (95% CrI 2.0%\u20137.9%) for multimorbidity. These findings suggest that social determinants and uncertainty estimates may provide useful information for cardiometabolic disease prediction, though further validation is needed before use in clinical practice.<\/jats:p>","DOI":"10.1038\/s41598-026-67901-3","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:46:44Z","timestamp":1787669204000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrating social and cardiometabolic risk factors in predicting cardiometabolic multimorbidity: a Bayesian model development and internal validation in Swedish middle-aged adults"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6832-0412","authenticated-orcid":false,"given":"Kanya","family":"Anindya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Merlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Jernberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Weinehall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Rosvall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Bendtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawi","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"issue":"7","key":"67901_CR1","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/eurheartj\/ehac744","volume":"44","author":"A Dove","year":"2023","unstructured":"Dove, A. et al. Cardiometabolic multimorbidity and incident dementia: the Swedish twin registry. Eur. Heart J. 44 (7), 573\u2013582 (2023).","journal-title":"Eur. Heart J."},{"key":"67901_CR2","doi-asserted-by":"publisher","first-page":"105447","DOI":"10.1016\/j.ebiom.2024.105447","volume":"109","author":"T Eroglu","year":"2024","unstructured":"Eroglu, T., Capone, F. & Schiattarella, G. G. The evolving landscape of cardiometabolic diseases. EBioMedicine 109, 105447 (2024).","journal-title":"EBioMedicine"},{"key":"67901_CR3","unstructured":"Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2023 (GBD 2023) (Institute for Health Metrics and Evaluation (IHME), 2025)."},{"issue":"5","key":"67901_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrendo.2014.29","volume":"10","author":"M Laakso","year":"2014","unstructured":"Laakso, M. & Kuusisto, J. Insulin resistance and hyperglycaemia in cardiovascular disease development. Nat. Rev. Endocrinol. 10 (5), 293\u2013302 (2014).","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"67901_CR5","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","volume":"314","author":"E Di Angelantonio","year":"2015","unstructured":"Di Angelantonio, E. et al. Association of cardiometabolic multimorbidity with mortality. J. Am. Med. Assoc. 314 (1), 52\u201360 (2015).","journal-title":"JAMA - J. Am. Med. Association"},{"issue":"1","key":"67901_CR6","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12939-025-02684-z","volume":"24","author":"K Anindya","year":"2025","unstructured":"Anindya, K. et al. Socio-geographical disparities in cardiometabolic multimorbidity in Sweden: an intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy (I-MAIHDA). Int. J. Equity Health 24 (1), 301 (2025).","journal-title":"Int. J. Equity Health"},{"issue":"1","key":"67901_CR7","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1007\/s10916-024-02087-7","volume":"48","author":"AB Teshale","year":"2024","unstructured":"Teshale, A. B., Htun, H. L., Vered, M., Owen, A. J. & Freak-Poli, R. A systematic review of artificial intelligence models for time-to-event outcome applied in cardiovascular disease risk prediction. J. Med. Syst. 48 (1), 68 (2024).","journal-title":"J. Med. Syst."},{"issue":"6","key":"67901_CR8","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","volume":"117","author":"RB D\u2019Agostino","year":"2008","unstructured":"D\u2019Agostino, R. B. et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 117 (6), 743\u2013753 (2008).","journal-title":"Circulation"},{"issue":"25","key":"67901_CR9","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 working group and ESC Cardiovascular risk collaboration","year":"2021","unstructured":"SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur. Heart J. 42 (25), 2439\u20132454 (2021).","journal-title":"Eur. Heart J."},{"key":"67901_CR10","doi-asserted-by":"crossref","unstructured":"Havranek, E. P. et al. Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement from the American Heart Association 873\u2013898 (Lippincott Williams and Wilkins, 2015).","DOI":"10.1161\/CIR.0000000000000228"},{"key":"67901_CR11","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2020.08.014","volume":"312","author":"A Stenling","year":"2020","unstructured":"Stenling, A., Haggstrom, C., Norberg, M. & Norstrom, F. Lifetime risk predictions for cardiovascular diseases: Competing risks analyses on a population-based cohort in Sweden. Atherosclerosis 312, 90\u201398 (2020).","journal-title":"Atherosclerosis"},{"key":"67901_CR12","doi-asserted-by":"crossref","unstructured":"Howell, C. R. et al. Cardiometabolic disease staging and major adverse cardiovascular event prediction in 2 prospective cohorts. JACC Adv. 3 (4) (2024).","DOI":"10.1016\/j.jacadv.2024.100868"},{"issue":"8","key":"67901_CR13","doi-asserted-by":"publisher","first-page":"e1003232","DOI":"10.1371\/journal.pmed.1003232","volume":"17","author":"L Wilkinson","year":"2020","unstructured":"Wilkinson, L., Yi, N., Mehta, T., Judd, S. & Garvey, W. T. Development and validation of a model for predicting incident type 2 diabetes using quantitative clinical data and a Bayesian logistic model: A nationwide cohort and modeling study. PLoS Med. 17 (8), e1003232 (2020).","journal-title":"PLoS Med."},{"issue":"1","key":"67901_CR14","doi-asserted-by":"publisher","first-page":"20","DOI":"10.7326\/M17-3011","volume":"169","author":"S Yadlowsky","year":"2018","unstructured":"Yadlowsky, S. et al. Clinical implications of revised pooled cohort equations for estimating atherosclerotic cardiovascular disease risk. Ann. Intern. Med. 169 (1), 20\u201329 (2018).","journal-title":"Ann. Intern. Med."},{"issue":"6","key":"67901_CR15","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","volume":"149","author":"SS Khan","year":"2024","unstructured":"Khan, S. S. et al. Development and validation of the American Heart Association\u2019s PREVENT equations. Circulation 149 (6), 430\u2013449 (2024).","journal-title":"Circulation"},{"key":"67901_CR16","doi-asserted-by":"crossref","unstructured":"Singh-Manoux, A. et al. Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: A cohort study. PLoS Med. 15 (5) (2018).","DOI":"10.1371\/journal.pmed.1002571"},{"issue":"20","key":"67901_CR17","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1161\/CIRCULATIONAHA.117.029652","volume":"137","author":"WM Schultz","year":"2018","unstructured":"Schultz, W. M. et al. Socioeconomic status and cardiovascular outcomes: challenges and interventions. Circulation 137 (20), 2166\u20132178 (2018).","journal-title":"Circulation"},{"issue":"5","key":"67901_CR18","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1161\/CIRCRESAHA.121.319811","volume":"130","author":"TM Powell-Wiley","year":"2022","unstructured":"Powell-Wiley, T. M. et al. Social determinants of cardiovascular disease. Circ. Res. 130 (5), 782\u2013799 (2022).","journal-title":"Circ. Res."},{"issue":"24","key":"67901_CR19","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1161\/CIRCULATIONAHA.120.053134","volume":"143","author":"MW Segar","year":"2021","unstructured":"Segar, M. W. et al. Development and validation of machine learning-based race-specific models to predict 10-year risk of heart failure: a multicohort analysis. Circulation 143 (24), 2370\u20132383 (2021).","journal-title":"Circulation"},{"issue":"9","key":"67901_CR20","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1161\/CIRCRESAHA.117.311312","volume":"121","author":"B Ambale-Venkatesh","year":"2017","unstructured":"Ambale-Venkatesh, B. et al. Cardiovascular event prediction by machine learning: The Multi-Ethnic Study of Atherosclerosis. Circ. Res. 121 (9), 1092\u20131101 (2017).","journal-title":"Circ. Res."},{"key":"67901_CR21","doi-asserted-by":"publisher","first-page":"111464","DOI":"10.1016\/j.jclinepi.2024.111464","volume":"173","author":"SHJ Hageman","year":"2024","unstructured":"Hageman, S. H. J. et al. Estimating uncertainty when providing individual cardiovascular risk predictions: a Bayesian survival analysis. J. Clin. Epidemiol. 173, 111464 (2024).","journal-title":"J. Clin. Epidemiol."},{"issue":"6","key":"67901_CR22","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/joim.12384","volume":"278","author":"G Bergstr\u00f6m","year":"2015","unstructured":"Bergstr\u00f6m, G. et al. The Swedish CArdioPulmonary BioImage study: objectives and design. J. Intern. Med. 278 (6), 645\u2013659 (2015).","journal-title":"J. Intern. Med."},{"key":"67901_CR23","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","volume":"385","author":"GS Collins","year":"2024","unstructured":"Collins, G. S. et al. TRIPOD\u2009+\u2009AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods. BMJ 385, e078378 (2024).","journal-title":"BMJ"},{"issue":"5","key":"67901_CR24","doi-asserted-by":"publisher","first-page":"e1002571","DOI":"10.1371\/journal.pmed.1002571","volume":"15","author":"A Singh-Manoux","year":"2018","unstructured":"Singh-Manoux, A. et al. Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: A cohort study. PLoS Med. 15 (5), e1002571 (2018).","journal-title":"PLoS Med."},{"key":"67901_CR25","unstructured":"Babor, T. F., Higgins-Biddle, J. C., Saunders, J. B. & Monteiro, M. G. The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care (World Health Organization, 2001)."},{"issue":"5","key":"67901_CR26","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/sms.14131","volume":"32","author":"E Ekblom-Bak","year":"2022","unstructured":"Ekblom-Bak, E. et al. Accelerometer derived physical activity patterns in 27.890 middle-aged adults: The SCAPIS cohort study. Scand. J. Med. Sci. Sports 32 (5), 866\u2013880 (2022).","journal-title":"Scand. J. Med. Sci. Sports"},{"issue":"18","key":"67901_CR27","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1161\/CIR.0000000000000444","volume":"134","author":"MP St-Onge","year":"2016","unstructured":"St-Onge, M. P. et al. Sleep duration and quality: Impact on lifestyle behaviors and cardiometabolic health: A scientific statement from the American Heart Association. Circulation 134 (18), e367\u2013e86 (2016).","journal-title":"Circulation"},{"issue":"9438","key":"67901_CR28","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0140-6736(04)17019-0","volume":"364","author":"A Rosengren","year":"2004","unstructured":"Rosengren, A. et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 364 (9438), 953\u2013962 (2004).","journal-title":"Lancet"},{"issue":"10","key":"67901_CR29","doi-asserted-by":"publisher","first-page":"e10873","DOI":"10.2196\/10873","volume":"20","author":"M Bendtsen","year":"2018","unstructured":"Bendtsen, M. A gentle introduction to the comparison between null hypothesis testing and Bayesian analysis: Reanalysis of two randomized controlled trials. J. Med. Internet Res. 20 (10), e10873 (2018).","journal-title":"J. Med. Internet Res."},{"issue":"4","key":"67901_CR30","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1214\/08-AOAS191","volume":"2","author":"A Gelman","year":"2008","unstructured":"Gelman, A., Jakulin, A., Pittau, M. & Su, Y. A weakly informative default prior distribution for logistic and other regression models. Ann. Appl. Stat. 2 (4), 1360\u20131383 (2008).","journal-title":"Annals Appl. Stat."},{"issue":"3","key":"67901_CR31","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/bjs.9736","volume":"102","author":"GS Collins","year":"2015","unstructured":"Collins, G. S., Reitsma, J. B., Altman, D. G. & Moons, K. G. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. Br. J. Surg. 102 (3), 148\u2013158 (2015).","journal-title":"Br. J. Surg."},{"key":"67901_CR32","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.ssmph.2017.08.005","volume":"3","author":"J Merlo","year":"2017","unstructured":"Merlo, J., Mulinari, S., Wemrell, M., Subramanian, S. V. & Hedblad, B. The tyranny of the averages and the indiscriminate use of risk factors in public health: The case of coronary heart disease. SSM Popul. Health 3, 684\u2013698 (2017).","journal-title":"SSM Popul. Health"},{"issue":"3","key":"67901_CR33","doi-asserted-by":"publisher","first-page":"e044922","DOI":"10.1161\/JAHA.125.044922","volume":"15","author":"AA Freedman","year":"2026","unstructured":"Freedman, A. A. et al. Sex differences in age of onset of premature cardiovascular disease and subtypes: the coronary artery risk development in young adults study. J. Am. Heart Assoc. 15 (3), e044922 (2026).","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"67901_CR34","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1177\/1403494817718906","volume":"46","author":"W Perini","year":"2018","unstructured":"Perini, W., Agyemang, C., Snijder, M. B., Peters, R. J. G. & Kunst, A. E. Ethnic disparities in educational and occupational gradients of estimated cardiovascular disease risk: The Healthy Life in an Urban Setting study. Scand. J. Public. Health 46 (2), 204\u2013213 (2018).","journal-title":"Scand. J. Public. Health"},{"issue":"10215","key":"67901_CR35","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/S0140-6736(19)32519-X","volume":"394","author":"FJ Brunner","year":"2019","unstructured":"Brunner, F. J. et al. Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium. Lancet 394 (10215), 2173\u20132183 (2019).","journal-title":"Lancet"},{"key":"67901_CR36","unstructured":"Dorie, V. et al. dbarts: Discrete Bayesian Additive Regression Trees Sampler 2019. https:\/\/cran.r-project.org\/web\/packages\/dbarts\/index.html (2025)."},{"key":"67901_CR37","first-page":"21164","volume":"118","author":"M Brunstr\u00f6m","year":"2021","unstructured":"Brunstr\u00f6m, M. et al. SCORE2 \u2013 ett uppdaterat verktyg f\u00f6r att skatta kardiovaskul\u00e4r risk. Lakartidningen 118, 21164 (2021).","journal-title":"Lakartidningen"},{"key":"67901_CR38","unstructured":"Stan Development Team. Stan Modeling Language Users Guide and Reference Manual 2022. https:\/\/mc-stan.org\/ (2025)."},{"issue":"3","key":"67901_CR39","first-page":"447","volume":"27","author":"LS Elinder","year":"2017","unstructured":"Elinder, L. S., Hakimi, S., Lager, A. & Patterson, E. Global region of birth is an independent risk factor for type 2 diabetes in Stockholm, Sweden. Eur. J. Public. Health 27 (3), 447\u2013453 (2017).","journal-title":"Eur. J. Public. Health"},{"key":"67901_CR40","doi-asserted-by":"crossref","unstructured":"Rose, G. The Strategy of Preventive Medicine (Oxford University Press, 1993).","DOI":"10.1093\/oso\/9780192624864.001.0001"},{"issue":"1","key":"67901_CR41","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12939-024-02291-4","volume":"23","author":"M Hassan","year":"2024","unstructured":"Hassan, M. et al. Perceived discrimination and refraining from seeking physician\u2019s care in Sweden: an intersectional analysis of individual heterogeneity and discriminatory accuracy (AIHDA). Int. J. Equity Health 23 (1), 199 (2024).","journal-title":"Int. J. Equity Health"},{"key":"67901_CR42","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.socscimed.2017.12.026","volume":"203","author":"J Merlo","year":"2018","unstructured":"Merlo, J. Multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA) within an intersectional framework. Soc. Sci. Med. 203, 74\u201380 (2018).","journal-title":"Soc. Sci. Med."},{"issue":"11","key":"67901_CR43","doi-asserted-by":"publisher","first-page":"6605","DOI":"10.1111\/dom.70067","volume":"27","author":"R Hua","year":"2025","unstructured":"Hua, R. et al. Social determinants of health and progression to cardio-renal-metabolic multimorbidity and mortality in people with prediabetes: A prospective cohort study. Diabetes Obes. Metab. 27 (11), 6605\u20136614 (2025).","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"67901_CR44","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12875-024-02446-w","volume":"25","author":"M Saleh","year":"2024","unstructured":"Saleh, M., Salminen, H. & Taloyan, M. The estimated 10-year risk of first-onset cardiovascular disease in Swedish-born and non-Swedish-born primary healthcare patients. BMC Prim. Care 25 (1), 198 (2024).","journal-title":"BMC Prim. Care"},{"key":"67901_CR45","doi-asserted-by":"crossref","unstructured":"Bywall, K. S., Norgren, T., Avagnina, B., Gonzalez, M. P. & Andersson, S. W. Promoting digital health literacy among immigrants in Sweden: opportunities and challenges for healthcare services. J. Public Health (2025).","DOI":"10.1007\/s10389-025-02496-z"},{"issue":"1","key":"67901_CR46","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1186\/s12889-024-18160-2","volume":"24","author":"FK Nkulu Kalengayi","year":"2024","unstructured":"Nkulu Kalengayi, F. K., Baroudi, M. & Hurtig, A. K. Prevalence of perceived discrimination, determinants and associations with self-rated general and sexual health, healthcare utilization and self-perceived integration: a cross-sectional survey of migrants in Sweden. BMC Public. Health. 24 (1), 699 (2024).","journal-title":"BMC Public. Health"},{"issue":"3","key":"67901_CR47","doi-asserted-by":"publisher","first-page":"e0265088","DOI":"10.1371\/journal.pone.0265088","volume":"17","author":"C Bonander","year":"2022","unstructured":"Bonander, C. et al. The value of combining individual and small area sociodemographic data for assessing and handling selective participation in cohort studies: Evidence from the Swedish CardioPulmonary bioImage Study. PLoS One. 17 (3), e0265088 (2022).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67901-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67901-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67901-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T14:52:10Z","timestamp":1787669530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-67901-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67901"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-67901-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"17 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used secondary pseudonymised data from the Swedish CArdioPulmonary bioImage Study (SCAPIS). The original SCAPIS data collection was approved by the ethics committee (Dnr 2010-228-31\u00a0M with supplements, EPN Ume\u00e5) and conducted in accordance with the Declaration of Helsinki. The secondary analysis was approved by the Swedish Ethical Review Board (Dnr 2022-03205-01). All methods were performed in accordance with the Swedish Ethical Review Act and relevant data protection regulations (GDPR). Individual informed consent was not required as the data were pseudonymised prior to access.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used pseudonymised national data and thus, patients and\/or the public were not involved in the design, conduct, reporting, or dissemination planning of the research.","order":3,"name":"Ethics","label":"Patient and public involvement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26679"}}